Product Description | hiPSC-Derived liver cells

NUOXINTE Biotechnology is committed to providing high-quality hepatosight derived from human induced stem cells (hiPSC) using optimized unique differentiation techniques®。 Hepatotoxicity is a common problem in new drug development and one of the main reasons for the failure of new drug development. At present, it mainly relies on primary liver cells lacking reproducibility or immortalized cells with abnormal phenotypes. Due to the inability of both to meet the requirements of in vitro studies, hiPSC derived liver cells Hepatosight® Can fill this gap. Hepatosight® is a high-purity and functionally active liver cell that can detect various metabolic applications such as albumin secretion, glycogen production, and CYP activity, ensuring reliable data for researchers. Hepatosight® is the perfect choice for testing tissue-specific studies, toxicity screening, efficacy testing, and drug discovery formulas. The Certificate of Analysis (CoA) contains the accurate results we have obtained, and our technical support team will continue to communicate with you to help you have a better experience in the laboratory.